CatalystFDA/Bio

MONOPAR: LICENSING AGREEMENT AND ROLLING NDA SUBMISSION SERVE AS CATALYSTS FOR 'STRONG BUY' - SEEKINGALPHA

Licensing agreement and rolling NDA submission are cited as catalysts for a 'Strong Buy' rating.

What changed

Licensing agreement and rolling NDA submission are cited as catalysts for a 'Strong Buy' rating.

Why it matters

Licensing agreement and rolling NDA submission are cited as catalysts for a 'Strong Buy' rating. — impact context not separately stored; see What changed.

Sources

seekingalpha